[PRK、LASIK和SMILE的远期疗效]。

4区 医学 Q3 Medicine Ophthalmologe Pub Date : 2022-02-01 Epub Date: 2021-07-09 DOI:10.1007/s00347-021-01449-7
Suphi Taneri, Jennifer Knepper, Anika Rost, H Burkhard Dick
{"title":"[PRK、LASIK和SMILE的远期疗效]。","authors":"Suphi Taneri,&nbsp;Jennifer Knepper,&nbsp;Anika Rost,&nbsp;H Burkhard Dick","doi":"10.1007/s00347-021-01449-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients and refractive surgeons have a legitimate interest in the long-term results of the most commonly used laser procedures for correction of ametropia.</p><p><strong>Objective: </strong>To assess the safety, predictability, stability and late complications according to the current recommendations of the committee for refractive surgery (KRC).</p><p><strong>Methods: </strong>Literature search in PubMed with the search term \"long-term outcome\" combined with either \"PRK\", \"LASIK\" or \"SMILE\". Articles about PRK and LASIK with a minimum follow-up of 10 years and SMILE with a minimum follow-up of 5 years were evaluated and duplications were eliminated.</p><p><strong>Results: </strong>From a total of 440 articles that matched these search terms 15 articles were selected and analyzed. The results of PRK were described in 4 studies with a total of 666 eyes, 7 studies (566 eyes) described the results of LASIK and 5 studies (188 eyes) the results after SMILE.</p><p><strong>Conclusion: </strong>Long-term studies with follow-up periods of at least 10 years have shown that PRK and LASIK treatment carried out in the early days of medical excimer lasers have a very high level of safety and late complications occurred only rarely. The effectiveness of particularly high corrections declined over time. In contrast, there was no clinically significant regression within the indications recommended by the KRC. The results of SMILE were not inferior to those of PRK and LASIK. In direct long-term comparisons no procedure showed a clear superiority. Due to technological improvements in hardware and software for both preoperative diagnostics and lasers, treatment performed nowadays is presumably even safer, more efficient and also more stable over a long period of time.</p>","PeriodicalId":54676,"journal":{"name":"Ophthalmologe","volume":"119 2","pages":"163-169"},"PeriodicalIF":0.0000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s00347-021-01449-7","citationCount":"7","resultStr":"{\"title\":\"[Long-term outcomes of PRK, LASIK and SMILE].\",\"authors\":\"Suphi Taneri,&nbsp;Jennifer Knepper,&nbsp;Anika Rost,&nbsp;H Burkhard Dick\",\"doi\":\"10.1007/s00347-021-01449-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Patients and refractive surgeons have a legitimate interest in the long-term results of the most commonly used laser procedures for correction of ametropia.</p><p><strong>Objective: </strong>To assess the safety, predictability, stability and late complications according to the current recommendations of the committee for refractive surgery (KRC).</p><p><strong>Methods: </strong>Literature search in PubMed with the search term \\\"long-term outcome\\\" combined with either \\\"PRK\\\", \\\"LASIK\\\" or \\\"SMILE\\\". Articles about PRK and LASIK with a minimum follow-up of 10 years and SMILE with a minimum follow-up of 5 years were evaluated and duplications were eliminated.</p><p><strong>Results: </strong>From a total of 440 articles that matched these search terms 15 articles were selected and analyzed. The results of PRK were described in 4 studies with a total of 666 eyes, 7 studies (566 eyes) described the results of LASIK and 5 studies (188 eyes) the results after SMILE.</p><p><strong>Conclusion: </strong>Long-term studies with follow-up periods of at least 10 years have shown that PRK and LASIK treatment carried out in the early days of medical excimer lasers have a very high level of safety and late complications occurred only rarely. The effectiveness of particularly high corrections declined over time. In contrast, there was no clinically significant regression within the indications recommended by the KRC. The results of SMILE were not inferior to those of PRK and LASIK. In direct long-term comparisons no procedure showed a clear superiority. Due to technological improvements in hardware and software for both preoperative diagnostics and lasers, treatment performed nowadays is presumably even safer, more efficient and also more stable over a long period of time.</p>\",\"PeriodicalId\":54676,\"journal\":{\"name\":\"Ophthalmologe\",\"volume\":\"119 2\",\"pages\":\"163-169\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s00347-021-01449-7\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmologe\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00347-021-01449-7\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/7/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmologe","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00347-021-01449-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/7/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 7

摘要

背景:患者和屈光外科医生对最常用的屈光不正激光矫正手术的长期效果有合法的兴趣。目的:根据美国屈光手术委员会(KRC)目前的建议,评估其安全性、可预测性、稳定性和后期并发症。方法:检索PubMed文献,检索词“long-term outcome”,并结合“PRK”、“LASIK”或“SMILE”。评估了最短随访10年的PRK和LASIK以及最短随访5年的SMILE的文献,并消除了重复的文献。结果:从总共440篇与这些搜索词相匹配的文章中,选择并分析了15篇文章。4项研究描述PRK的结果,共666只眼,7项研究(566只眼)描述LASIK的结果,5项研究(188只眼)描述SMILE后的结果。结论:随访期至少10年的长期研究表明,在医用准分子激光的早期进行PRK和LASIK治疗具有非常高的安全性,晚期并发症很少发生。特别高的修正的有效性随着时间的推移而下降。相比之下,在KRC推荐的适应症范围内,没有临床显著的倒退。SMILE的效果不逊于PRK和LASIK。在直接的长期比较中,没有一种方法显示出明显的优越性。由于术前诊断和激光的硬件和软件技术的改进,现在进行的治疗可能更安全,更有效,而且在很长一段时间内更稳定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Long-term outcomes of PRK, LASIK and SMILE].

Background: Patients and refractive surgeons have a legitimate interest in the long-term results of the most commonly used laser procedures for correction of ametropia.

Objective: To assess the safety, predictability, stability and late complications according to the current recommendations of the committee for refractive surgery (KRC).

Methods: Literature search in PubMed with the search term "long-term outcome" combined with either "PRK", "LASIK" or "SMILE". Articles about PRK and LASIK with a minimum follow-up of 10 years and SMILE with a minimum follow-up of 5 years were evaluated and duplications were eliminated.

Results: From a total of 440 articles that matched these search terms 15 articles were selected and analyzed. The results of PRK were described in 4 studies with a total of 666 eyes, 7 studies (566 eyes) described the results of LASIK and 5 studies (188 eyes) the results after SMILE.

Conclusion: Long-term studies with follow-up periods of at least 10 years have shown that PRK and LASIK treatment carried out in the early days of medical excimer lasers have a very high level of safety and late complications occurred only rarely. The effectiveness of particularly high corrections declined over time. In contrast, there was no clinically significant regression within the indications recommended by the KRC. The results of SMILE were not inferior to those of PRK and LASIK. In direct long-term comparisons no procedure showed a clear superiority. Due to technological improvements in hardware and software for both preoperative diagnostics and lasers, treatment performed nowadays is presumably even safer, more efficient and also more stable over a long period of time.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ophthalmologe
Ophthalmologe 医学-眼科学
CiteScore
1.80
自引率
0.00%
发文量
95
审稿时长
4-8 weeks
期刊介绍: Der Ophthalmologe is an internationally recognized journal dealing with all aspects of ophthalmology. The journal serves both the scientific exchange and the continuing education of ophthalmologists. Freely submitted original papers allow the presentation of important clinical studies and serve scientific exchange. Case reports feature interesting cases and aim at optimizing diagnostic and therapeutic strategies. Comprehensive reviews on a specific topical issue focus on providing evidenced based information on diagnostics and therapy. Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.
期刊最新文献
Myelin Oligodendrocyte Glycoprotein Antibody-Mediated Optic Neuritis Following COVID-19 Vaccination. [Acute unilateral impaired vision after COVID vaccination]. [Epidemiology and treatment of retinopathy of prematurity. The Hannover data in the Retina.net ROP registry from 2001-2017]. [Displacement of a STARflo glaucoma drainage implant with accompanying complications]. [Complete visual recovery after Nd:YAG laser polishing of the anterior surface of the intraocular lens].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1